In the second part of our interview series, SABEU's CEO, Dennis Benkmann, reconnects with Celean Camp, the CEO of FRAME (Fund for the Replacement of Animals in Medical Experiments). This time, the focus shifts towards the impactful role FRAME plays in supporting biomedical research and testing, particularly in addressing human diseases and treatments.
Celean highlights FRAME's significant achievement in establishing ECVAM (European Commission for the Validation of Alternative Methods), demonstrating the organisation's commitment to pioneering alternative testing methods. Working with FRAME is characterised by a close-knit team culture where there is transparency about challenges and opportunities. Driven by passion, team members and partners are working together to make a significant difference in the field of non-animal testing.
Stay tuned for more insights as we continue our interview series with part three next week.